Skip to main content

Drugs Approved for Childhood Cancers

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for use in children. The list includes generic and brand names. The drug names link to NCI's Cancer Drug Information summaries. There are drugs and drug combinations used to treat children with cancer that are not listed here.

Drugs Approved for Colorectal Cancer

Drugs Approved for Epithelioid Sarcoma

Tazemetostat Hydrobromide (Tazverik)

Drugs Approved for Ewing Sarcoma

Dactinomycin (Cosmegen)

Drugs Approved for Gestational Trophoblastic Disease

Dactinomycin (Cosmegen)

Drugs Approved for Giant Cell Astrocytoma

Everolimus

Drugs Approved for Hodgkin Lymphoma

Drugs Approved for Leukemia

Drugs Approved for Acute Lymphoblastic Leukemia (ALL)

Drugs Approved for Acute Myeloid Leukemia (AML)

Drugs Approved for Blastic Plasmacytoid Dendritic Cell Neoplasm

Drugs Approved for Chronic Myelogenous Leukemia (CML)

Drugs Approved for Melanoma

Drugs Approved for Merkel Cell Carcinoma

Drugs Approved for Neuroblastoma

Drugs Approved for Neurofibromatosis Type 1

Drugs Approved for Non-Hodgkin Lymphoma

Drugs Approved for Pheochromocytoma and Paraganglioma

Drugs Approved for Rhabdomyosarcoma

Drugs Approved for Solid Tumors Anywhere in the Body

Drugs Approved for Wilms Tumor

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Drugs Approved for Childhood Cancers was originally published by the National Cancer Institute.”